These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles. Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE J Neurosci Methods; 2009 Feb; 177(1):177-82. PubMed ID: 18992277 [TBL] [Abstract][Full Text] [Related]
10. Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity. Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE Synapse; 2009 Feb; 63(2):147-51. PubMed ID: 19021208 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. Brown JM; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904 [TBL] [Abstract][Full Text] [Related]
12. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614 [TBL] [Abstract][Full Text] [Related]
13. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422 [TBL] [Abstract][Full Text] [Related]
14. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Riddle EL; Topham MK; Haycock JW; Hanson GR; Fleckenstein AE Eur J Pharmacol; 2002 Aug; 449(1-2):71-4. PubMed ID: 12163108 [TBL] [Abstract][Full Text] [Related]